Free Trial

Natera (NTRA) Stock Price, News & Analysis

Natera logo
$161.50 -0.07 (-0.04%)
Closing price 07/3/2025 03:54 PM Eastern
Extended Trading
$161.50 0.00 (0.00%)
As of 07/3/2025 04:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Natera Stock (NASDAQ:NTRA)

Key Stats

Today's Range
$160.72
$163.17
50-Day Range
$149.40
$171.87
52-Week Range
$92.14
$183.00
Volume
468,868 shs
Average Volume
1.42 million shs
Market Capitalization
$22.05 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$184.63
Consensus Rating
Buy

Company Overview

Natera Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
43rd Percentile Overall Score

NTRA MarketRank™: 

Natera scored higher than 43% of companies evaluated by MarketBeat, and ranked 1987th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Natera has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 15 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Natera has only been the subject of 3 research reports in the past 90 days.

  • Read more about Natera's stock forecast and price target.
  • Earnings Growth

    Earnings for Natera are expected to grow in the coming year, from ($1.49) to ($1.25) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Natera is -109.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Natera is -109.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Natera has a P/B Ratio of 17.85. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Natera's valuation and earnings.
  • Percentage of Shares Shorted

    4.95% of the float of Natera has been sold short.
  • Short Interest Ratio / Days to Cover

    Natera has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in Natera has recently increased by 3.83%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Natera does not currently pay a dividend.

  • Dividend Growth

    Natera does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.95% of the float of Natera has been sold short.
  • Short Interest Ratio / Days to Cover

    Natera has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in Natera has recently increased by 3.83%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Natera has a news sentiment score of 1.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 20 news articles for Natera this week, compared to 14 articles on an average week.
  • Search Interest

    Only 4 people have searched for NTRA on MarketBeat in the last 30 days. This is a decrease of -43% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Natera to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Natera insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $8,345,368.00 in company stock.

  • Percentage Held by Insiders

    Only 7.60% of the stock of Natera is held by insiders.

  • Percentage Held by Institutions

    99.90% of the stock of Natera is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Natera's insider trading history.
Receive NTRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Natera and its competitors with MarketBeat's FREE daily newsletter.

NTRA Stock News Headlines

Natera, Inc. (NASDAQ:NTRA) Insider Sells $500,310.00 in Stock
Something very strange is happening...
What a "Mar-a-Lago Accord" could mean for the U.S. dollar While protests dominate the news... hardly anyone noticed when the U.S. Senate granted sweeping powers to a Harvard economist who has some dangerous ideas about the U.S. dollar. Now, he's issued a blueprint for what a coming "Mar-a-Lago Accord" could look like. One analyst who predicted the 2008 crisis says this plan could see the dollar fall in value by 40% in months and become a national nightmare.
Should You Invest in Natera (NTRA)?
See More Headlines

NTRA Stock Analysis - Frequently Asked Questions

Natera's stock was trading at $158.30 on January 1st, 2025. Since then, NTRA stock has increased by 2.0% and is now trading at $161.50.

Natera, Inc. (NASDAQ:NTRA) announced its quarterly earnings results on Thursday, May, 8th. The medical research company reported ($0.50) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.59) by $0.09. Natera's revenue was up 36.5% compared to the same quarter last year.
Read the conference call transcript
.

Natera (NTRA) raised $101 million in an IPO on Thursday, July 2nd 2015. The company issued 6,300,000 shares at $15.00-$17.00 per share. Morgan Stanle, Cowen and Company and Piper Jaffray served as the underwriters for the IPO and Baird and Wedbush Pacgrow were co-managers.

Top institutional investors of Natera include Central Pacific Bank Trust Division and Harbor Investment Advisory LLC. Insiders that own company stock include Roelof Botha, Matthew Rabinowitz, Daniel Rabinowitz, Steven Leonard Chapman, John Fesko, Solomon Moshkevich, Michael Burkes Brophy, Herm Rosenman, Jonathan Sheena, James Healy, Gail Boxer Marcus, Rowan E Chapman and Robert Alan Schueren.
View institutional ownership trends
.

Shares of NTRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Natera investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AU Optronics (AUOTY).

Company Calendar

Last Earnings
5/08/2025
Today
7/04/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:NTRA
Fax
N/A
Employees
4,434
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$184.63
High Stock Price Target
$251.00
Low Stock Price Target
$125.00
Potential Upside/Downside
+14.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
15 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$190.43 million
Pretax Margin
-10.34%

Debt

Sales & Book Value

Annual Sales
$1.83 billion
Price / Cash Flow
N/A
Book Value
$9.05 per share
Price / Book
17.85

Miscellaneous

Free Float
126,169,000
Market Cap
$22.05 billion
Optionable
Optionable
Beta
1.73

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:NTRA) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners